Part 1: Clinical Evaluation
This section truly discusses the clinical evaluation associated with the 2022 regulatory change. In accordance with order 739, there will be some significant updates to clinical evaluation in 2021. In order to concisely describe preferred clinical examination pathways, the speaker also provides examples. Then it discusses Suggestions for a Successful Clinical Assessment in 2023. This section also contains information about the Human Genetic Resources Administration of China (HGRAC).
